nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—Chills—Fludarabine—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Misoprostol—Arrhythmia—Fludarabine—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Misoprostol—Alopecia—Fludarabine—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Misoprostol—Hypertension—Teniposide—lymphatic system cancer	0.00459	0.00459	CcSEcCtD
Misoprostol—Chest pain—Teniposide—lymphatic system cancer	0.00452	0.00452	CcSEcCtD
Misoprostol—Pneumonia—Bleomycin—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Misoprostol—Dehydration—Vincristine—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Misoprostol—Confusional state—Teniposide—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Misoprostol—Oedema—Teniposide—lymphatic system cancer	0.00433	0.00433	CcSEcCtD
Misoprostol—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00433	0.00433	CcSEcCtD
Misoprostol—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Misoprostol—Anaemia—Fludarabine—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Misoprostol—Infection—Teniposide—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Misoprostol—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Misoprostol—Dehydration—Mitoxantrone—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Misoprostol—Dysphagia—Carmustine—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Misoprostol—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Misoprostol—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Misoprostol—Haematuria—Bleomycin—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Misoprostol—Hypotension—Teniposide—lymphatic system cancer	0.00405	0.00405	CcSEcCtD
Misoprostol—Gingivitis—Methotrexate—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Misoprostol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Misoprostol—Myalgia—Fludarabine—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Misoprostol—Arthralgia—Fludarabine—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Misoprostol—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Misoprostol—Dyspnoea—Teniposide—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Misoprostol—Pneumonia—Carmustine—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Misoprostol—Confusional state—Fludarabine—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Misoprostol—Dysuria—Vincristine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Misoprostol—Oedema—Fludarabine—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Misoprostol—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Misoprostol—Infection—Fludarabine—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Misoprostol—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Misoprostol—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Misoprostol—Vomiting—Mechlorethamine—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Misoprostol—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Misoprostol—Urinary tract infection—Carmustine—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Misoprostol—Rash—Mechlorethamine—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Misoprostol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Misoprostol—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Misoprostol—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Misoprostol—Pneumonia—Vincristine—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Misoprostol—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Misoprostol—Myocardial infarction—Vincristine—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Misoprostol—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Misoprostol—Pneumonia—Mitoxantrone—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Misoprostol—Feeling abnormal—Teniposide—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Misoprostol—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Misoprostol—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Misoprostol—Musculoskeletal stiffness—Methotrexate—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Misoprostol—Chills—Bleomycin—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Misoprostol—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Misoprostol—Nausea—Mechlorethamine—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Misoprostol—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Misoprostol—Alopecia—Bleomycin—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Misoprostol—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Misoprostol—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Misoprostol—Abdominal pain—Teniposide—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Misoprostol—Body temperature increased—Teniposide—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Misoprostol—Dyspnoea—Fludarabine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Misoprostol—Haematuria—Mitoxantrone—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Misoprostol—Dyspepsia—Fludarabine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Misoprostol—Visual impairment—Carmustine—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Misoprostol—Fatigue—Fludarabine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Misoprostol—Inflammation—Methotrexate—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Misoprostol—Constipation—Fludarabine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Misoprostol—Pain—Fludarabine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Misoprostol—Hypersensitivity—Teniposide—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Misoprostol—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Misoprostol—Anaemia—Bleomycin—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Misoprostol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Misoprostol—Asthenia—Teniposide—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Misoprostol—Arrhythmia—Carmustine—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Misoprostol—Alopecia—Carmustine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Misoprostol—Body temperature increased—Fludarabine—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Misoprostol—Diarrhoea—Teniposide—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Misoprostol—Chest pain—Bleomycin—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Misoprostol—Myalgia—Bleomycin—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Misoprostol—Alopecia—Vincristine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Misoprostol—Back pain—Carmustine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Misoprostol—Chills—Mitoxantrone—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Misoprostol—Urine output increased—Methotrexate—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Misoprostol—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Misoprostol—Alopecia—Mitoxantrone—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Misoprostol—Confusional state—Bleomycin—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Misoprostol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Misoprostol—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Misoprostol—Oedema—Bleomycin—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Misoprostol—Infection—Bleomycin—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Misoprostol—Anaemia—Carmustine—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Misoprostol—Back pain—Vincristine—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Misoprostol—Vomiting—Teniposide—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Misoprostol—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Misoprostol—Asthenia—Fludarabine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Misoprostol—Rash—Teniposide—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Misoprostol—Dermatitis—Teniposide—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Misoprostol—Headache—Teniposide—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Misoprostol—Back pain—Mitoxantrone—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Misoprostol—Anaemia—Vincristine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Misoprostol—Polyuria—Methotrexate—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Misoprostol—Hypotension—Bleomycin—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Misoprostol—Diarrhoea—Fludarabine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Misoprostol—Hypertension—Carmustine—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Misoprostol—Nausea—Teniposide—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Misoprostol—Anaemia—Mitoxantrone—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Misoprostol—Chest pain—Carmustine—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Misoprostol—Myalgia—Carmustine—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Misoprostol—Anxiety—Carmustine—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Misoprostol—Dyspnoea—Bleomycin—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Misoprostol—Hypertension—Vincristine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Misoprostol—Confusional state—Carmustine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Misoprostol—Oedema—Carmustine—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Misoprostol—Myalgia—Vincristine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Misoprostol—Infection—Carmustine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Misoprostol—Vomiting—Fludarabine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Misoprostol—Rash—Fludarabine—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Misoprostol—Dermatitis—Fludarabine—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Misoprostol—Hypertension—Mitoxantrone—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Misoprostol—Pain—Bleomycin—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Misoprostol—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Misoprostol—Headache—Fludarabine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Misoprostol—Chest pain—Mitoxantrone—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Misoprostol—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Misoprostol—Myalgia—Mitoxantrone—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Misoprostol—Anxiety—Mitoxantrone—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Misoprostol—Oedema—Vincristine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Misoprostol—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Misoprostol—Infection—Vincristine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Misoprostol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Misoprostol—Confusional state—Mitoxantrone—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Misoprostol—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Misoprostol—Hypotension—Carmustine—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Misoprostol—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Misoprostol—Oedema—Mitoxantrone—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Misoprostol—Nausea—Fludarabine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Misoprostol—Infection—Mitoxantrone—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Misoprostol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Misoprostol—Shock—Mitoxantrone—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Misoprostol—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Misoprostol—Body temperature increased—Bleomycin—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Misoprostol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Misoprostol—Hypotension—Vincristine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Misoprostol—Dyspnoea—Carmustine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Misoprostol—Somnolence—Carmustine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Misoprostol—Hypotension—Mitoxantrone—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Misoprostol—Pain—Carmustine—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Misoprostol—Constipation—Carmustine—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Misoprostol—Breast disorder—Methotrexate—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Misoprostol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Misoprostol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Misoprostol—Somnolence—Mitoxantrone—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Misoprostol—Feeling abnormal—Carmustine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Misoprostol—Fatigue—Vincristine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Misoprostol—Asthenia—Bleomycin—lymphatic system cancer	0.002	0.002	CcSEcCtD
Misoprostol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.002	0.002	CcSEcCtD
Misoprostol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Misoprostol—Constipation—Vincristine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Misoprostol—Pain—Vincristine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Misoprostol—Fatigue—Mitoxantrone—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Misoprostol—Pain—Mitoxantrone—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Misoprostol—Constipation—Mitoxantrone—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Misoprostol—Body temperature increased—Carmustine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Misoprostol—Abdominal pain—Carmustine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Misoprostol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Misoprostol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Misoprostol—Dysuria—Methotrexate—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Misoprostol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Misoprostol—Abdominal pain—Vincristine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Misoprostol—Body temperature increased—Vincristine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Misoprostol—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Misoprostol—Hypersensitivity—Carmustine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Misoprostol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Misoprostol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Misoprostol—Pneumonia—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Misoprostol—Vomiting—Bleomycin—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Misoprostol—Drowsiness—Methotrexate—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Misoprostol—Rash—Bleomycin—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Misoprostol—Dermatitis—Bleomycin—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Misoprostol—Asthenia—Carmustine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Misoprostol—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Misoprostol—Hypersensitivity—Vincristine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Misoprostol—Haematuria—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Misoprostol—Epistaxis—Methotrexate—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Misoprostol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Misoprostol—Asthenia—Vincristine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Misoprostol—Diarrhoea—Carmustine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Misoprostol—Nausea—Bleomycin—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Misoprostol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Misoprostol—Dizziness—Carmustine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Misoprostol—Diarrhoea—Vincristine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Misoprostol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Misoprostol—Vomiting—Carmustine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Misoprostol—Dizziness—Vincristine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Misoprostol—Rash—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Misoprostol—Dermatitis—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Misoprostol—Visual impairment—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Misoprostol—Headache—Carmustine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Misoprostol—Tinnitus—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Misoprostol—Vomiting—Vincristine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Misoprostol—Rash—Vincristine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Misoprostol—Dermatitis—Vincristine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Misoprostol—Headache—Vincristine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Misoprostol—Nausea—Carmustine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Misoprostol—Vomiting—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Misoprostol—Immune system disorder—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Misoprostol—Rash—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Misoprostol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Misoprostol—Chills—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Misoprostol—Headache—Mitoxantrone—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Misoprostol—Alopecia—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Misoprostol—Nausea—Vincristine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Misoprostol—Nausea—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Misoprostol—Back pain—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Misoprostol—Anaemia—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Misoprostol—Chest pain—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Misoprostol—Myalgia—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Misoprostol—Arthralgia—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Misoprostol—Confusional state—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Misoprostol—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Misoprostol—Infection—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Misoprostol—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Misoprostol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Misoprostol—Hypotension—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Misoprostol—Dyspnoea—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Misoprostol—Somnolence—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Misoprostol—Dyspepsia—Methotrexate—lymphatic system cancer	0.000994	0.000994	CcSEcCtD
Misoprostol—Fatigue—Methotrexate—lymphatic system cancer	0.000974	0.000974	CcSEcCtD
Misoprostol—Pain—Methotrexate—lymphatic system cancer	0.000966	0.000966	CcSEcCtD
Misoprostol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000931	0.000931	CcSEcCtD
Misoprostol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000923	0.000923	CcSEcCtD
Misoprostol—Abdominal pain—Methotrexate—lymphatic system cancer	0.000893	0.000893	CcSEcCtD
Misoprostol—Body temperature increased—Methotrexate—lymphatic system cancer	0.000893	0.000893	CcSEcCtD
Misoprostol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000832	0.000832	CcSEcCtD
Misoprostol—Asthenia—Methotrexate—lymphatic system cancer	0.00081	0.00081	CcSEcCtD
Misoprostol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000773	0.000773	CcSEcCtD
Misoprostol—Dizziness—Methotrexate—lymphatic system cancer	0.000747	0.000747	CcSEcCtD
Misoprostol—Vomiting—Methotrexate—lymphatic system cancer	0.000718	0.000718	CcSEcCtD
Misoprostol—Rash—Methotrexate—lymphatic system cancer	0.000712	0.000712	CcSEcCtD
Misoprostol—Dermatitis—Methotrexate—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Misoprostol—Headache—Methotrexate—lymphatic system cancer	0.000707	0.000707	CcSEcCtD
Misoprostol—Nausea—Methotrexate—lymphatic system cancer	0.000671	0.000671	CcSEcCtD
